Global Blood Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch GBT and buy or sell other stocks, ETFs, and their options commission-free!

About GBT

GBT is a clinical-stage biopharmaceutical company that focuses on discovering, developing, and delivering innovative treatments that provide hope to underserved patient communities. GBT is developing its product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. 

CEO
Bert Bruce
CEOBert Bruce
Employees
Employees
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2011
Founded2011
Employees
Employees

GBT Key Statistics

Market cap
4.62B
Market cap4.62B
Price-Earnings ratio
-13.70
Price-Earnings ratio-13.70
Dividend yield
Dividend yield
Average volume
2.06M
Average volume2.06M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$73.02
52 Week high$73.02
52 Week low
$21.65
52 Week low$21.65
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.